FCCC LOGO Faculty Publications
Francescone R , Hou V , Grivennikov SI
Cytokines, IBD, and Colitis-associated Cancer
Inflamm Bowel Dis. 2015 Feb;21(2) :409-18
PMID: 25563695    PMCID: PMC4481731    URL: https://www.ncbi.nlm.nih.gov/pubmed/25563695
Back to previous list
Abstract
: Inflammatory bowel diseases (IBDs) are debilitating conditions that result in intestinal damage due to chronic inflammation. In addition, the perpetual state of inflammation predisposes individuals to the development of colitis-associated cancer. Because of the immense immune cell infiltration into colon, cytokines produced by immune cells are major players in the initiation and progression of IBD and colitis-associated cancer. In this review, we will explore the functions of many key cytokines and their roles in IBD and colitis-associated cancer, as well as their influences on the immune system and stromal cells. Finally, we will briefly discuss current therapies and current clinical trials targeting cytokines in IBD.
Notes
1536-4844 Francescone, Ralph Hou, Vivianty Grivennikov, Sergei I Journal Article United States Inflamm Bowel Dis. 2015 Feb;21(2):409-18. doi: 10.1097/MIB.0000000000000236.